Loading...
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers
BACKGROUND. The frequency with which targeted tumor sequencing results will lead to implemented change in care is unclear. Prospective assessment of the feasibility and limitations of using genomic sequencing is critically important. METHODS. A prospective clinical study was conducted on 100 patient...
Na minha lista:
Udgivet i: | Oncologist |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
AlphaMed Press
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5189630/ https://ncbi.nlm.nih.gov/pubmed/27566247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0049 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|